Effect of the structure of ginsenosides on the in vivo fate of their liposomes

被引:26
作者
Chen, Chen [1 ,2 ]
Xia, Jiaxuan [1 ,2 ]
Ren, Hongwei [1 ,2 ]
Wang, Anni [1 ,2 ]
Zhu, Ying [1 ,2 ,3 ]
Zhang, Ru [1 ,2 ]
Gan, Zicheng [1 ,2 ]
Wang, Jianxin [1 ,2 ,4 ]
机构
[1] Fudan Univ, Sch Pharm, Dept Pharmaceut, Shanghai 201203, Peoples R China
[2] Minist Educ, Key Lab Smart Drug Delivery, Shanghai 201203, Peoples R China
[3] Guangzhou Univ Chinese Med, Inst Trop Med, Guangzhou 510006, Peoples R China
[4] Fudan Univ, Inst Integrated Chinese & Western Med, Shanghai 200040, Peoples R China
基金
中国国家自然科学基金;
关键词
Ginsenosides; Liposomes; Structure activity relationship; Rg3; liposomes; Long circulation; Tumor targeting; Glut; 1; GLUT-1; EXPRESSION; BREAST-CANCER; MECHANISM; CHOLESTEROL; ABSORPTION; STABILITY; GINSENG;
D O I
10.1016/j.ajps.2021.12.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To utilize the multiple functions and give full play of ginsenosides, a variety of ginsenosides with different structures were prepared into liposomes and evaluated for their effect on the stability, pharmacokinetics and tumor targeting capability of liposomes. The results showed that the position and number of glycosyl groups of ginsenosides have significant effect on the in vitro and in vivo properties of their liposomes. The pharmacokinetics of ginsenosides liposomes indicated that the C-3 sugar group of ginsenosides is beneficial to their liposomes for longer circulation in vivo. The C-3 and C-6 glycosyls can enhance the uptake of their liposomes by 4T1 cells, and the glycosyls at C-3 position can enhance the tumor active targeting ability significantly, based on the specific binding capacity to Glut 1 expressed on the surface of 4T1 cells. According to the results in the study, ginsenoside Rg3 and ginsenoside Rh2 are potential for exploiting novel liposomes because of their cholesterol substitution, long blood circulation and tumor targeting capabilities. The results provide a theoretical basis for further development of ginsenoside based liposome delivery systems. (C) 2022 Shenyang Pharmaceutical University. Published by Elsevier B.V.
引用
收藏
页码:219 / 229
页数:11
相关论文
共 33 条
[1]  
Avril N, 2004, J NUCL MED, V45, P930
[2]   Influence of cholesterol on liposome stability and on in vitro drug release [J].
Briuglia, Maria-Lucia ;
Rotella, Chiara ;
McFarlane, Amber ;
Lamprou, Dimitrios A. .
DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2015, 5 (03) :231-242
[3]  
BROWN RS, 1993, CANCER, V72, P2979, DOI 10.1002/1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0.CO
[4]  
2-X
[5]  
Cantuaria G, 2001, CANCER-AM CANCER SOC, V92, P1144, DOI 10.1002/1097-0142(20010901)92:5<1144::AID-CNCR1432>3.0.CO
[6]  
2-T
[7]   The in Vitro Structure-Related Anti-Cancer Activity of Ginsenosides and Their Derivatives [J].
Dong, Hang ;
Bai, Li-Ping ;
Wong, Vincent Kam Wai ;
Zhou, Hua ;
Wang, Jing-Rong ;
Liu, Yan ;
Jiang, Zhi-Hong ;
Liu, Liang .
MOLECULES, 2011, 16 (12) :10619-10630
[8]   The anti-tumor effect of ginsenoside Rh4 in MCF-7 breast cancer cells in vitro and in vivo [J].
Duan, Zhiguang ;
Wei, Bo ;
Deng, Jianjun ;
Mi, Yu ;
Dong, Yangfang ;
Zhu, Chenhui ;
Fu, Rongzhan ;
Qu, Linlin ;
Fan, Daidi .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 499 (03) :482-487
[9]   Shenyi Capsule plus Chemotherapy versus Chemotherapy for Non-Small Cell Lung Cancer: A Systematic Review of Overlapping Meta-Analyses [J].
Guo, Xiu-wei ;
Hu, Nai-dong ;
Sun, Gui-zhi ;
Li, Meng ;
Zhang, Pei-tong .
CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2018, 24 (03) :227-231
[10]   One Stone Four Birds: A Novel Liposomal Delivery System Multi-functionalized with Ginsenoside Rh2 for Tumor Targeting Therapy [J].
Hong, Chao ;
Liang, Jianming ;
Xia, Jiaxuan ;
Zhu, Ying ;
Guo, Yizhen ;
Wang, Anni ;
Lu, Chunyi ;
Ren, Hongwei ;
Chen, Chen ;
Li, Shiyi ;
Wang, Dan ;
Zhan, Huaxing ;
Wang, Jianxin .
NANO-MICRO LETTERS, 2020, 12 (01)